Nuzenio

Attovia Therapeutics Announces

Attovia Therapeutics Announces news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 20 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 20:31:25 GMTAttovia Therapeutics (ATTO) major holder converts 18.2M preferred into common - Stock Titan
Mon, 10 Aug 2026 20:12:43 GMTAttovia Therapeutics (ATTO): venBio fund converts preferred in IPO, buys $17 shares - Stock Titan
Mon, 10 Aug 2026 13:26:21 GMTAttovia Therapeutics (ATTO) CFO discloses two long-dated stock option grants - Stock Titan
Mon, 10 Aug 2026 13:26:21 GMTAttovia Therapeutics (ATTO) insider reports initial stock and option holdings - Stock Titan
Mon, 10 Aug 2026 13:26:21 GMTAttovia Therapeutics (ATTO) director discloses 72,792-share option grant and vesting terms - Stock Titan
Sat, 08 Aug 2026 18:11:44 GMTAttovia Therapeutics (ATTO) director Angie You receives 27,000 stock options at $17 - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Attovia Therapeutics Announces.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.